La empagliflozina disminuye la mortalidad cardiovascular y el riesgo de hospitalización en pacientes con insuficiencia cardíaca

Ponce de León, Natalia Jimena

La empagliflozina disminuye la mortalidad cardiovascular y el riesgo de hospitalización en pacientes con insuficiencia cardíaca / Empagliflozin decreases cardiovascular mortality and the risk of hospitalization in heart failure patients

Ponce de León, Natalia Jimena.

Ponce de León, Natalia Jimena; Hospital Italiano de Buenos Aires. Servicio de Medicina Familiar y Comunitaria. Ciudad Autónoma de Buenos Aires. AR

Evid. actual. práct. ambul ; 24(4): e002159, 2021. tab

Article in Spanish | LILACS, UNISALUD, BINACIS | ID: biblio-1362082

Subject(s)

Humans; Male; Female; Middle Aged; Aged; Benzhydryl Compounds/therapeutic use; Cardiovascular Diseases/prevention & control; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use; Glucosides/therapeutic use; Heart Failure/drug therapy; Benzhydryl Compounds/adverse effects; Cardiovascular Diseases/mortality; Randomized Controlled Trials as Topic; Multicenter Studies as Topic; Disease Progression; Diabetes Mellitus, Type 2/complications; Sodium-Glucose Transporter 2 Inhibitors/adverse effects; Glucosides/adverse effects; Heart Failure/complications; Heart Failure/physiopathology; Hospitalization/statistics & numerical data

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Benzhydryl Compounds / Cardiovascular Diseases / Sodium-Glucose Transporter 2 Inhibitors / Glucosides / Heart Failure Type of study: Controlled clinical trial / Etiology study / Risk factors Limits: Aged / Female / Humans / Male Language: Spanish Journal: Evid. actual. práct. ambul Year: 2021 Type: Article Institution/Affiliation country: Hospital Italiano de Buenos Aires/AR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google